Rob Thomas has formally taken over from Peter Bartels as chairman of Starpharma (ASX:SPL) following a seven-month transition period. [ + ]

AsureQuality has recieved certification for the contract manufacture of in vitro diagnostic medical devices. [ + ]

AusBiotech has released the results of the Biotechnology Industry Position Survey (2014). The survey finds that advanced manufacturing associated with the biotech industry is following traditional manufacturing and heading overseas. [ + ]

AsureQuality, a contract manufacturer of in vitro diagnostics, has announced it has achieved ISO 13485:2012 certification for the contract manufacture of in vitro diagnostic medical devices (IVDs). [ + ]

Initial results of the Eucalyptus genome sequence have been revealed. [ + ]

A hearing into the alleged fraud against Phosphagenics has resulted in two men pleading guilty to issuing false invoices worth millions of dollars. [ + ]

LBT Innovations' (ASX:LBT) partner in the JV set up to oversee the development of its Automated Plate Assessment System has paid out a third $1m milestone payment. [ + ]

Scientists at Thermo Fisher Scientific and BioAnalytix are combining their expertise to develop advanced analytical profiling platforms and applications to characterise biologic and biosimilar drugs. [ + ]

This year's National Health and Medical Research Council's prizes for excellence in health and medical research have been announced. [ + ]

WA Premier and Minister for Science Colin Barnett has announced Professor Peter Klinken as the new Chief Scientist of Western Australia. Professor Klinken is a leading medical researcher who is highly regarded for advancing the understanding of genes involved in leukaemia, cancer and anaemia. [ + ]

Genetic Technologies' (ASX:GTG) new CFO, Eutillio Buccilli, has more than 35 years of senior management experience. [ + ]

Another step has been taken in understanding the link between glutamic acid decarboxylase and type 1 diabetes. [ + ]

Treasury has confirmed that issues raised in submissions to its review of 'employee share schemes (ESS) and start-ups' will be considered by the Prime Minister's taskforce established to develop a National Industry Investment and Competitiveness Agenda, which is expected to be delivered in the coming weeks. [ + ]

Alchemia (ASX:ACL) now expects top-line results from its phase III trial of HA-Irinotecan in colorectal cancer to be ready in Q3, and aims to file FDA and EMA submissions in 1H15. [ + ]

German biotechnology company ibidi has revealed a device that optically measures the exact oxygen content directly in cells and tissues. The ibidi OPAL Optical O2 Measurement System determines the correct O₂ content, which is a critical factor in maintaining the natural behaviour of cells in culture. [ + ]